Cargando…
ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome
BACKGROUND: It is unclear why primary nephrotic syndrome (PNS) patients often have dyslipidemia. Recent studies have shown that angiopoietin-like protein 3 (ANGPTL3) is an important regulator of lipid metabolism. In this study, we explored how ANGPTL3 impacts dyslipidemia during PNS development. MET...
Autores principales: | Zhong, Fu, Liu, Shurao, Li, Yue, Li, Guanyu, Liu, Ming, Wang, Jingzhi, Cui, Weijing, Suo, Yanhong, Gao, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996604/ https://www.ncbi.nlm.nih.gov/pubmed/35399079 http://dx.doi.org/10.1186/s12944-022-01632-y |
Ejemplares similares
-
Serum and urine ANGPTL8 expression levels are associated with hyperlipidemia and proteinuria in primary nephrotic syndrome
por: Li, Yue, et al.
Publicado: (2021) -
Angiopoietin-like protein 3 markedly enhanced in the hyperlipidemia related proteinuria
por: Gao, Xia, et al.
Publicado: (2019) -
ANGPTL3 is involved in kidney injury in high-fat diet-fed mice by suppressing ACTN4 expression
por: Li, Guanyu, et al.
Publicado: (2022) -
Primary IgA nephropathy with nephrotic-range proteinuria in Chinese children
por: Zhao, Jing-Li, et al.
Publicado: (2021) -
ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis
por: Mohamed, Farzahna, et al.
Publicado: (2022)